Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
| Autor: | Cylie Alflen OMS-III, Katheryn Birch DO, Ryan Shilian DO, Shan Shan Wu DO, Robert Hostoffer DO |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Allergy & Rhinology, Vol 12 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2152-6567 21526567 |
| DOI: | 10.1177/21526567211026271 |
| Popis: | Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive agents may be administered. Exacerbating factors include stress, environmental conditions, medications, physical stimuli, and infections. We report the first two cases of a COVID-19 vaccine triggered relapse of CSU that was previously well controlled on therapy. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|